Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | March 03, 2017

Dynamic 4D Prostate Imaging with DISCO

MRI

Images courtesy of Levanger Hospital, Norway.

Over 30 years of innovation delivers our most advanced MR system ever, the SIGNA Architect. Fueled by the SIGNAWorks productivity platform, this novel technology delivers greater speed, acuity and consistency than ever thought possible. Dynamic and versatile, the advances in imaging capabilities are clearly visible. For prostate imaging, obtain 4D, high-resolution imaging with DynamIc SCan Optimization (DISCO). DISCO combines 3D DCEMRI, two-point Dixon, parallel imaging and temporal acceleration to drastically reduce scan time. Experience the potential to eliminate bolus timing with scans produced in less than 1 second, and by sampling the center of k-space more frequently, get better clarity of the rapidly changing contrast dynamics of the prostate. We imagined what MR can be and the result is the SIGNA Architect.

A patient was referred to MR for further evaluation of a potential ectopic BPH (benign prostatic hyperplasia). The patient initially underwent a TRUS, transrectal-ultrasound, exam, but further examination showed the possibility of a high-grade tumor. Due to the mass’s proximity to the right nerve bundle and rectum, an MR exam was performed to help identify a more precise location for a lesion biopsy. The DynamIc SCan Optimization (DISCO) 4D imaging technique was used as part of the MR exam on the SIGNA Architect. With scan times of :06 sec/phase, DISCO potentially eliminates bolus timing techniques. DISCO and four pulse sequences were used according to the PIRADS report: (T2 3, DWI 5, DCE +, ADC 450), size 12 mm. 

For more information, visit our SIGNA Architect or SIGNAWorks sites.

 

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...